STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more
STAT News · LC · trust 58/100
Eli Lilly confirmed that it will allow more patients to apply for early access to retatrutide, an unapproved obesity drug
Read the original at STAT News →
Open in TruthVane →